Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin

被引:34
|
作者
Holley, JL [1 ]
Elmore, M
Mauchline, M
Minton, N
Titball, RW
机构
[1] Def Evaluat & Res Agcy, CBD Porton Down, Salisbury SP4 0JQ, Wilts, England
[2] Ctr Appl Microbiol & Res, Salisbury SP4 0JQ, Wilts, England
关键词
FHc subunit; botulinum; vaccine;
D O I
10.1016/S0264-410X(00)00155-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A synthetic gene encoding the He (binding) domain of Clostridium botulinum neurotoxin F (FHc) was expressed in Escherichia coli fused to maltose binding protein (MBP). The purified MBP-FHc and FHc isolated after removal of MBP were evaluated in mice for their ability to protect against toxin challenge. Balb/c mice developed a protective immune response following administration of either protein via the intraperitoneal or intramuscular routes. A comparison of antibody titres and protection following single and multiple vaccinations and the effects of dosage are shown. The long term protection afforded by the vaccines was also investigated. Ten months following vaccination mice were still protected when challenged with 10(4) MLD50 doses of botulinum toxin F. Crown Copyright (C) 2000 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:288 / 297
页数:10
相关论文
共 50 条
  • [21] PRODUCTION AND EVALUATION OF A SINGLE RECOMBINANT VACCINE AGAINST BOTULINUM NEUROTOXIN TYPES A AND B
    Choi, Eun Sun
    Rhie, Gi-eun
    Joan, Jun Ho
    TOXICON, 2018, 156 : S16 - S17
  • [22] Inactivated recombinant Escherichia coli as a candidate vaccine against Clostridium perfringens alpha toxin in sheep
    Ferreira, Marcos Roberto A.
    Motta, Jaqueline F.
    Azevedo, Morgana L.
    dos Santos, Lucas M.
    Moreira Junior, Clovis
    Rodrigues, Rafael R.
    Donassolo, Rafael A.
    Belo Reis, Alessandra dos S.
    Barbosa, Jose D.
    Salvarani, Felipe M.
    Moreira, Angela N.
    Conceicao, Fabricio R.
    ANAEROBE, 2019, 59 : 163 - 166
  • [23] Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro
    Ekong, TAN
    Feavers, IM
    Sesardic, D
    MICROBIOLOGY-SGM, 1997, 143 : 3337 - 3347
  • [24] Novel Structural Elements within the Nonproteolytic Clostridium botulinum Type F Toxin Gene Cluster
    Dover, N.
    Barash, J. R.
    Hill, K. K.
    Detter, J. C.
    Arnon, S. S.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2011, 77 (05) : 1904 - 1906
  • [25] Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F
    Yu, Yun-Zhou
    Zhang, Shu-Ming
    Ma, Yao
    Zhu, Heng-Qi
    Wang, Wen-Bing
    Du, Yun
    Zhou, Xiao-Wei
    Wang, Rui-Lin
    Wang, Shuang
    Yu, Wei-Yuan
    Huang, Pei-Tang
    Sun, Zhi-Wei
    CLINICAL IMMUNOLOGY, 2010, 137 (02) : 271 - 280
  • [26] FAILURE OF A DENGUE-1 SUB-UNIT VACCINE TO PROTECT MICE AGAINST A LETHAL DENGUE VIRUS-INFECTION
    AASKOV, JG
    WILLIAMS, L
    FLETCHER, J
    HAY, R
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 39 (05): : 511 - 518
  • [27] 3 DIFFERENT MONOCLONAL-ANTIBODIES AGAINST TYPE-C TOXIN OF CLOSTRIDIUM-BOTULINUM
    OGUMA, K
    AGUI, T
    SYUTO, B
    IIDA, H
    KUBO, S
    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1982, 35 (03): : 128 - 129
  • [28] PRODUCTION OF MONOCLONAL-ANTIBODIES AGAINST CLOSTRIDIUM-BOTULINUM TYPE-E DERIVATIVE TOXIN
    KAMATA, Y
    KOZAKI, S
    NAGAI, T
    SAKAGUCHI, G
    FEMS MICROBIOLOGY LETTERS, 1985, 26 (03) : 305 - 309
  • [29] Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A
    Chaddock, JA
    Herbert, MH
    Ling, RJ
    Alexander, FCG
    Fooks, SJ
    Revell, DF
    Quinn, CP
    Shone, CC
    Foster, KA
    PROTEIN EXPRESSION AND PURIFICATION, 2002, 25 (02) : 219 - 228
  • [30] A mutated recombinant subunit vaccine protects mice and guinea pigs against botulinum type A intoxication
    Yu, Chi Ho
    Song, Dong Hyun
    Choi, Jun Young
    Joe, Hae Eun
    Jeong, Woo Hyeon
    Hur, Gyeung Haeng
    Shin, Young Kee
    Jeong, Seong Tae
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 329 - 336